APA (7th ed.) Citation

MY, A., AJ, K., NP, S., KJ, S., KA, M., & A, P. (2022). Safety of BNT162b2 mRNA vaccine booster in the setting of Ad26.COV2.S-associated VITT. Blood advances, 6(18), 5327. https://doi.org/10.1182/bloodadvances.2022007753

Chicago Style (17th ed.) Citation

MY, Abou-Ismail, Kanack AJ, Splinter NP, Smock KJ, Moser KA, and Padmanabhan A. "Safety of BNT162b2 MRNA Vaccine Booster in the Setting of Ad26.COV2.S-associated VITT." Blood Advances 6, no. 18 (2022): 5327. https://doi.org/10.1182/bloodadvances.2022007753.

MLA (9th ed.) Citation

MY, Abou-Ismail, et al. "Safety of BNT162b2 MRNA Vaccine Booster in the Setting of Ad26.COV2.S-associated VITT." Blood Advances, vol. 6, no. 18, 2022, p. 5327, https://doi.org/10.1182/bloodadvances.2022007753.